Term
|
Definition
Omeprazole
PPI
Dose 20-40 mg qd
Capsule and granules |
|
|
Term
|
Definition
Omeprazole
PPI
20mg qd x 14 days
Tablet |
|
|
Term
|
Definition
Omeprazole + Sodium Bicarb
PPI + antacid
20-40 mg qd
Capsule and Powder for oral suspension |
|
|
Term
|
Definition
Omeprazole + Sodium Bicarb
PPI + antacid
20 mg qd
Capsule |
|
|
Term
|
Definition
Esomeprazole
PPI
20-40 mg qd
Capsule, IV, Granules for oral suspension |
|
|
Term
|
Definition
Lansoprazole
PPI
15 mg qd - 30 mg BID
Capsule, ODT, Liquid, Solu tab |
|
|
Term
|
Definition
Lansoprazole
PPI
15 mg qd
capsule |
|
|
Term
|
Definition
Dexlansoprazole
PPI
30-60 mg qd
capsule |
|
|
Term
|
Definition
Rabeprazole
PPI
10-20 mg qd
Tablet |
|
|
Term
|
Definition
Pantoprazole
PPI
40-80 mg qd
Tablet, Granules, IV |
|
|
Term
|
Definition
Cimetidine
H2-RA
300 mg qid - 800 mg hs
Tablet, Liquid, IV |
|
|
Term
|
Definition
Ranitidine
H2 RA
150 mg BID - 300 mg hs
Tablet, liquid, IV, capsule, Effervescent tablet |
|
|
Term
|
Definition
Nizatidine
H2RA
150 mg BID - 300 mg hs
capsule, liquid, tablet |
|
|
Term
|
Definition
Famotidine
h2 ra
20 mg BID - 40 mg HS
Tablet, capsule , powder for oral suspension, IV |
|
|
Term
|
Definition
Clarithromycin
Antibacterial
500 mg BID x 10-14 days
tablet, granuals for oral suspension |
|
|
Term
|
Definition
Amoxicillin
antibacterial
1 g BID x 10-14 days
Tablet, powder for oral suspension, Chewable tablet |
|
|
Term
|
Definition
Metronidazole
Antibacterial
500 mg TID x 10-14 days
tablet, capsule, IV |
|
|
Term
| Tetracycline has various trade names |
|
Definition
Tetracycline
Antibacterial
500 mg qid x 10-14 days
capsule |
|
|
Term
|
Definition
Sucralfate
cytoprotective
1 g QID
Tablet and liquid |
|
|
Term
| Triple therapy for PUD caused by H Pylori. This is the initial therapy |
|
Definition
PPI
Clarithromycin
Amoxicillin OR Metronidazole
for 14 days |
|
|
Term
| Quadrubple therapy for PUD caused by H Pylori if Triple therapy fails |
|
Definition
Bismuth
Metronidazole
Ttracycline
H2RA OR PPI
for 10 -14 dyas |
|
|
Term
| NSAID induced PUD, treatment includes: |
|
Definition
1. D/c offending agent
2. PPI or H2 RA for 4 weeks
From then on if patient requires NSAID, PPI, H2RA or misoprostol should be used to prevent ulcers |
|
|
Term
|
Definition
Magnesium hydroxide
antacid
15-30 ml PRN
tablet and liquid |
|
|
Term
|
Definition
Aluminum hydroxide
antacid
15-30ml PRN
tablet and liquid |
|
|
Term
|
Definition
Aluminum carbonate
antacid
15-30ml PRN
tablet and liquid |
|
|
Term
|
Definition
Magnesium hydroxide + aluminum hydroxide
antacid
15-30ml PRN
tablet and liquid |
|
|
Term
|
Definition
Magaldrate
antacid
15-30ml PRN
tablet and liquid |
|
|
Term
|
Definition
Calcium Carbonate
antacid
15-30ml PRN
tablet and liquid |
|
|
Term
| Various trade names for Sodium bicarb |
|
Definition
Sodium bicarbonate
antacid
15-30ml PRN
tablet and liquid |
|
|
Term
|
Definition
Alginic acid + aluminum hydroxide + magnesium hydroxide
antacid + absorbent
15-30ml PRN; 2 after meals
tablet and liquid |
|
|
Term
|
Definition
Sulfasalazine
Aminosalicylate
Dose: 4-6 g/day
Tablet |
|
|
Term
|
Definition
Mesalamin
Aminosalicylate
Dose: 2.4 - 4.8 g/day
Delayed release tablet |
|
|
Term
|
Definition
Mesalamine
Aminosalicylate
Dose: 2-4 g/day
delayed release capsule |
|
|
Term
|
Definition
Mesalamine
Aminosalicylate
Dose: 1-4 g/day
Enema, Suppository |
|
|
Term
|
Definition
Mesalamine
Aminosalicylate
2.4-5.8 g/day
Delayed release tablet |
|
|
Term
|
Definition
Mesalamine
500-1,000 mg
Aminosalicylate
Suppository |
|
|
Term
|
Definition
Balsalazide
Aminosalicylate
6.75 g/d
delayed release capsule |
|
|
Term
|
Definition
Metronidazole
Antibacterial
10-20 g/day (Crohn's Disease)
Tablet and IV |
|
|
Term
|
Definition
Ciprofloxacin
Antibacterial
500 mg BID (Crohn's disease)
Tablet and IV |
|
|
Term
| various trade names for prednisone |
|
Definition
Prednisone
corticosteroid
40-60 mg/day
tablet |
|
|
Term
|
Definition
Methylprednisolone
corticosteriod
16 mg q8h
IV |
|
|
Term
|
Definition
Budesonide
corticosteriod
9 mg qd
capsule |
|
|
Term
|
Definition
Azathioprine
immunosuppresant
1-2.5 mg/kg/day
tablet and Iv |
|
|
Term
|
Definition
6-mercaptopurine
immunosuppressive
1.5mg/kg/day
tablet |
|
|
Term
|
Definition
Methotrexate
antimetabolite
25mg/wk
Tablet |
|
|
Term
|
Definition
Infliximab
immunomodulator
Induction 5mg/kg at 0,2, 6 weeks
maintenance: 5mg/kg q 8 weeks
IV |
|
|
Term
|
Definition
Adalimumab
immunomodulator
Induction: 160 mg as 4 injections over 1-2 days then 80 mg 2 weeks later;
Maintenance: 40 mg q other week starting on day 29
SC |
|
|
Term
|
Definition
Certolizumab pegol
immunomodulator
Induction 400 mg (given as 2 separate doses of 200 mg) at 0,2,and 4 weeks
Maintenance: 400 mg q 4 weeks
SC |
|
|
Term
|
Definition
Natalizumab
immunomodulator
300 mg over 1 hr every 4 weks
IV |
|
|
Term
|
Definition
cyclosporin
immunosuppressive
4mg/kg/d
iv, capsule, liquid |
|
|
Term
|
Definition
Dicyclomine
Antispasmodic, anticholinergic
10-20 mg qid prn
tablet, capsule, liquid |
|
|
Term
Various trade names for Hyoscyamine
Jami sobs........ |
|
Definition
Hyoscyamine
anticholinergic
0.25 - 0.5 mg BID-QID
tablet, liquid |
|
|
Term
|
Definition
Amitriptyline
TCA
10-50 mg qhs
tablet |
|
|
Term
|
Definition
Paroxetine
SSRI
10-60 mg/d
tablet, liquid, delayed release tablet |
|
|
Term
|
Definition
Tegaserod
seratonin receptor antagonist
6 mg bid
tablet |
|
|
Term
| various trade names for lactulose |
|
Definition
Lactulose
osmotic laxative
30-45 ml BID- QID PRN
liquid |
|
|
Term
|
Definition
Polycarbophil
bulking agent
1 g qd-qid prn
tablet |
|
|
Term
| Various trade names for polyethylene glycol |
|
Definition
polyethylene glycol
osmotic laxative
250ml q 10 min up to 4 L
liquid |
|
|
Term
|
Definition
Alosetron
Seratonin receptor antagonist
1mg qd-bid
tablet
improves global IBS symptoms in women with diarrhea-predominant IBS... only available through prescribing program |
|
|
Term
|
Definition
Lubiprostone
C-2 cholroide channel activator 8 mcg BID
Capsule
Shown to releave globalIBS symptoms in women with constipation-predominant IBS |
|
|
Term
|
Definition
Loperamide
Antidarrheal
2 mg after each loose stool; max 16mg/d
tablet, capsule, liquid |
|
|
Term
|
Definition
Diphenoxylate/atropine
antidarrheal
15-20 mg/d of diphenoxylate in 3-4 divided doses
tablet and liquid |
|
|
